Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cost-effectiveness analysis of romosozumab for severe postmenopausal osteoporosis at very high risk of fracture in Mexico.

Subjects: Cost-Benefit Analysis* ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/economics

  • Source: PloS one [PLoS One] 2025 Feb 07; Vol. 20 (2), pp. e0299673. Date of Electronic Publication: 2025 Feb 07 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

×
  • 1-10 ل  96 نتائج ل ""denosumab""